Development of an invasive ductal carcinoma in a contralateral composite nipple graft after an autologous breast reconstruction: a case report.
Autologous breast reconstruction
Breast cancer
Composite nipple grafting
Contralateral breast cancer
Deep inferior epigastric perforator flap
Donor nipple
Invasive cancer of graft
Nipple graft
Nipple-areola complex reconstruction
Reconstructed nipple
Journal
Surgical case reports
ISSN: 2198-7793
Titre abrégé: Surg Case Rep
Pays: Germany
ID NLM: 101662125
Informations de publication
Date de publication:
08 Aug 2020
08 Aug 2020
Historique:
received:
31
01
2020
accepted:
27
07
2020
entrez:
10
8
2020
pubmed:
10
8
2020
medline:
10
8
2020
Statut:
epublish
Résumé
Nipple-areola complex (NAC) reconstruction is a technique used in breast reconstructive surgery, which is performed during the final stage of breast reconstruction after total mastectomy of primary breast cancer. Composite nipple grafts utilizing the contralateral NAC are common; however, to our knowledge, there are no reports of new primary invasive ductal carcinoma development within the graft. Here, we describe one such case for the first time. A 54-year-old woman was referred to us by the Department of Plastic and Reconstructive Surgery in our medical center for further evaluation of right nipple erosion. She had undergone total mastectomy of the right breast following a breast cancer diagnosis 15 years ago, at which time tumor biological profiling revealed the following: estrogen receptor (ER), positive; progesterone receptor (PgR), negative; and human epidermal growth factor receptor 2 (HER2), undetermined. She received adjuvant chemotherapy and endocrine therapy. She defaulted endocrine therapy for a few years, and 7 years after surgery, she underwent autologous breast reconstruction with a deep inferior epigastric perforator (DIEP) flap. In the following year, NAC reconstruction was performed using a composite graft technique. Seven years after the NAC reconstruction, erosion appeared on the nipple grafted from its contralateral counterpart; scrape cytology revealed malignancy. The skin on the right side of her chest around the NAC and subcutaneous fat tissue consisted of transferred tissue from the abdomen, as the DIEP flap and grafted nipple were located on the graft skin. The right nipple carcinoma arose from the tissue taken from the left nipple. Magnetic resonance imaging (MRI) or computed tomography showed no malignant findings in the left breast. As the malignant lesion seemed limited to the area around the grafted right nipple on MRI, surgical resection with sufficient lateral and deep margins was performed around the right nipple. Pathological findings revealed invasive ductal carcinoma with comedo ductal components infiltrating the graft skin and underlying adipose tissue. Immunohistochemistry revealed positive for ER, PgR, and HER2. To our knowledge, this is the first case involving the development of invasive ductal carcinoma in a nipple graft constructed on the skin of a DIEP flap, with the origin from the contralateral breast's nipple.
Sections du résumé
BACKGROUND
BACKGROUND
Nipple-areola complex (NAC) reconstruction is a technique used in breast reconstructive surgery, which is performed during the final stage of breast reconstruction after total mastectomy of primary breast cancer. Composite nipple grafts utilizing the contralateral NAC are common; however, to our knowledge, there are no reports of new primary invasive ductal carcinoma development within the graft. Here, we describe one such case for the first time.
CASE PRESENTATION
METHODS
A 54-year-old woman was referred to us by the Department of Plastic and Reconstructive Surgery in our medical center for further evaluation of right nipple erosion. She had undergone total mastectomy of the right breast following a breast cancer diagnosis 15 years ago, at which time tumor biological profiling revealed the following: estrogen receptor (ER), positive; progesterone receptor (PgR), negative; and human epidermal growth factor receptor 2 (HER2), undetermined. She received adjuvant chemotherapy and endocrine therapy. She defaulted endocrine therapy for a few years, and 7 years after surgery, she underwent autologous breast reconstruction with a deep inferior epigastric perforator (DIEP) flap. In the following year, NAC reconstruction was performed using a composite graft technique. Seven years after the NAC reconstruction, erosion appeared on the nipple grafted from its contralateral counterpart; scrape cytology revealed malignancy. The skin on the right side of her chest around the NAC and subcutaneous fat tissue consisted of transferred tissue from the abdomen, as the DIEP flap and grafted nipple were located on the graft skin. The right nipple carcinoma arose from the tissue taken from the left nipple. Magnetic resonance imaging (MRI) or computed tomography showed no malignant findings in the left breast. As the malignant lesion seemed limited to the area around the grafted right nipple on MRI, surgical resection with sufficient lateral and deep margins was performed around the right nipple. Pathological findings revealed invasive ductal carcinoma with comedo ductal components infiltrating the graft skin and underlying adipose tissue. Immunohistochemistry revealed positive for ER, PgR, and HER2.
CONCLUSIONS
CONCLUSIONS
To our knowledge, this is the first case involving the development of invasive ductal carcinoma in a nipple graft constructed on the skin of a DIEP flap, with the origin from the contralateral breast's nipple.
Identifiants
pubmed: 32770432
doi: 10.1186/s40792-020-00962-2
pii: 10.1186/s40792-020-00962-2
pmc: PMC7415053
doi:
Types de publication
Journal Article
Langues
eng
Pagination
203Références
Eur J Surg Oncol. 2016 Apr;42(4):441-65
pubmed: 26868167
Arch Pathol Lab Med. 2013 Jul;137(7):955-60
pubmed: 23808467
BMC Cancer. 2018 Oct 19;18(1):994
pubmed: 30340548
J Surg Oncol. 2016 Jun;113(8):865-74
pubmed: 26918920
CA Cancer J Clin. 1981 Sep-Oct;31(5):281-3
pubmed: 6269713
Mol Carcinog. 2017 Apr;56(4):1199-1213
pubmed: 27787930
Ann Plast Surg. 1994 Jan;32(1):32-8
pubmed: 8141534
Nat Rev Cancer. 2008 Mar;8(3):180-92
pubmed: 18273037
Surg Gynecol Obstet. 1956 Aug;103(2):185-92
pubmed: 13352143
Histopathology. 2020 Feb 13;:
pubmed: 32056259
Arch Pathol Lab Med. 2018 May;142(5):598-605
pubmed: 29431468
Endocr J. 2009;56(1):1-7
pubmed: 18497452
Cancer Treat Rev. 2001 Feb;27(1):9-18
pubmed: 11237774
CA Cancer J Clin. 1982 May-Jun;32(3):187-8
pubmed: 6804039
Ann Plast Surg. 2008 Feb;60(2):144-5
pubmed: 18216504